KLA stock jumps after TSMC capex signal and fresh Wall Street upgrades — what investors watch next
16 January 2026
1 min read

KLA stock jumps after TSMC capex signal and fresh Wall Street upgrades — what investors watch next

New York, January 15, 2026, 18:10 EST — After-hours

  • KLA shares jumped roughly 8% in late trading, riding a wave across the chip-equipment sector
  • TSMC’s boost to its 2026 spending forecast sent shockwaves across the sector
  • Ahead of KLA’s earnings report on Jan. 29, analysts are raising their price targets

KLA Corp shares climbed 7.7% to $1,544.96 in after-hours trading Thursday, following a session that saw the stock fluctuate between $1,487.53 and $1,571.19.

The boost came after Taiwan Semiconductor Manufacturing Co exceeded expectations and raised its 2026 capital expenditure forecast to $52 billion-$56 billion. That increase sparked fresh optimism about chipmaking investments, with some analysts suggesting it could ease concerns over a slowdown in AI-driven demand. “The market has underestimated again how large is the demand for AI, and the implementation is going faster than everybody expected,” said Han Dieperink, chief investment officer at Aureus. 1

KLA sees a clear takeaway: as chip features shrink, spending rises, driving demand for more inspection and measurement tools. These instruments are essential for “process control,” helping chipmakers spot defects and maintain yields even as manufacturing grows more complex.

Wells Fargo bumped KLA up to Overweight from Equal Weight, lifting its price target to $1,600 from $1,250. The firm highlighted ongoing strength in advanced nodes like 2-nanometer manufacturing and a pickup in high-performance computing demand. 2

Stifel bumped up its price target on KLA to $1,600 from $1,260, maintaining a Buy rating. The firm pointed out that spending on process control usually remains steady even when the equipment cycle declines. It also highlighted growing use of extreme ultraviolet lithography (EUV), a chipmaking method for finer features, as a boost for demand in inspection and metrology. 3

Bernstein SocGen kicked off coverage on KLA with an Outperform rating and set a $1,700 price target. The firm projects low double-digit revenue growth alongside mid-double-digit earnings gains in the coming years, despite noting the stock’s valuation appears high compared to peers. 4

The rally wasn’t confined to TSMC’s U.S.-listed shares. Chip-tool makers mostly climbed as well, with investors betting on a pickup in spending across the equipment supply chain, including names like Applied Materials and Lam Research. 5

That said, the situation is a double-edged sword. Capex plans often shift quickly if end-demand falters, and tool orders can delay despite chipmakers’ upbeat spending talk. Export controls and customer concentration continue to weigh heavily on U.S. equipment suppliers, while rapid gains leave little margin for any earnings shortfall.

KLA is set to report its second-quarter fiscal 2026 earnings on Jan. 29 at 2 p.m. PT, with the results coming after the U.S. market closes. 6

Stock Market Today

Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Visa stock dips after UK fee-cap ruling as stablecoin push builds into earnings
Previous Story

Visa stock dips after UK fee-cap ruling as stablecoin push builds into earnings

UnitedHealth stock climbs as UnitedHealthcare rolls out fast-pay Medicare Advantage pilot for rural hospitals
Next Story

UnitedHealth stock climbs as UnitedHealthcare rolls out fast-pay Medicare Advantage pilot for rural hospitals

Go toTop